How much funding has Cartesian Therapeutics raised?

Cartesian Therapeutics has raised $130.0M in total funding.

Who are Cartesian Therapeutics's investors?

Cartesian Therapeutics's investors include HBM Healthcare Investments, Invus, Schooner Capital, Surveyor Capital.

When was Cartesian Therapeutics founded?

Cartesian Therapeutics was founded in 2016.

Where is Cartesian Therapeutics headquartered?

Cartesian Therapeutics is headquartered in Gaithersburg, Maryland, United States.

What industry is Cartesian Therapeutics in?

Cartesian Therapeutics operates in Biotech, Healthcare.

How many employees does Cartesian Therapeutics have?

Cartesian Therapeutics has 51-200 employees.

Cartesian Therapeutics

IPO

Home - Cartesian Therapeutics

Public · Gaithersburg, United States · Founded 2016 · $130.0M raised

Biotech

Healthcare

Headquarters: Gaithersburg, Maryland
Employees: 51–200
Founded: 2016
Business Model: B2B

Website: cartesiantherapeutics.com
Total Funding: $130.0M
Type: Public

About

Cartesian Therapeutics is a NASDAQ-listed clinical-stage biotechnology company pioneering mRNA cell therapies for autoimmune diseases. Its lead program, Descartes-08, is an autologous mRNA-engineered CAR-T therapy targeting BCMA in patients with myasthenia gravis and other autoimmune conditions. Founded in 2016, the company merged with Selecta Biosciences in November 2023 and is based in Gaithersburg, Maryland.

Summary

Cartesian Therapeutics is a Biotech company based in Gaithersburg, United States, founded in 2016. It has raised $130.0M in total. Investors include HBM Healthcare Investments, Invus and Schooner Capital.

LinkedIn X (Twitter)